The OSMA Division of Regulatory Affairs actively monitors the activities of state and federal regulatory agencies. If necessary, the OSMA engages with the agency and/or submits comments to the agency that is drafting new or amended rules. Advocating the OSMA’s position on draft rules is one of the most active points of involvement in the entire regulatory process.
For more information, contact Jennifer Hayhurst
, OSMA Director of Regulatory Affairs, (614) 527-6762.
OSMA Rule Watch
The OSMA is actively monitoring the following rules:
State Medical Board of Ohio
The rule number is a link to the rule and a memo explaining the proposed action.
Ohio State Board of Pharmacy
- Updated Drug Compounding Rules - effective 5/2016
- Compounding Rules Update! (5-11-16)
Due to recent feedback regarding the prescriber compounding rules, the pharmacy board is advising previously exempt prescriber practices to refrain from application to the Board as a Terminal Distributor of Dangerous Drugs until after the Board’s June 2016 meeting. As a result, rule changes will not apply to these prescriber practices.
Access an updated guidance document on this issue here.
After consideration of the feedback received, the pharmacy board will be posting additional guidance on its web site following the June 2016 meeting. Prescribers and prescriber associations are encouraged to sign up for web updates by visiting: www.pharmacy.ohio.gov/update
Ohio Bureau of Workers' Compensation